The global implantable neurostimulators market size is anticipated to reach USD 11.0 billion by 2027, expanding at a CAGR of 11.7%, according to a new report by Grand View Research, Inc. Increasing incidence of neurological diseases and higher occurrence of associated chronic pain and discomfort are driving the market.
The rising prevalence of neurological diseases such as Parkinson’s disease, epilepsy, essential tremor, chronic pain, and depression will result in increased demand for implantable neurostimulators. According to the WHO, in 2020, around 50.0 million people worldwide are suffering from epilepsy. Implanted neurostimulators are used to control epileptic seizures. Thus, increasing people suffering from epilepsy is expected to boost the market growth.
Moreover, the growing base of the aging population is more susceptible to neurological disorders, which is anticipated to be a high-impact rendering driver for this market. According to the CDC, Parkinson’s disease (PD) is mostly diagnosed in individuals above the age of 60 and it is projected that PD affects 1.0% of the people over the age of 60 to 4% by age of 80.
Furthermore, the incorporation of new technologies, and the introduction of new products by market players, is likely to boost the market during the forecast period. For instance, in September 2019, Abbott received U.S. FDA approval for its Proclaim XR recharge-free SCS system for the management of chronic pain.
Request a Sample Copy of the Implantable Neurostimulators Market Research Report @ https://www.grandviewresearch.com/industry-analysis/implantable-neurostimulators-market/request/rs1
Implantable Neurostimulators Market Report Highlights
Have Any Query? Ask Our Experts@ https://www.grandviewresearch.com/inquiry/450982/ibb
Implantable Neurostimulators Market Segmentation
Grand View Research has segmented the global implantable neurostimulators market on the basis of type, application, and region:
Implantable Neurostimulators Type Outlook (Revenue, USD Million, 2016 – 2027)
Implantable Neurostimulators Application Outlook (Revenue, USD Million, 2016 – 2027)
Implantable Neurostimulators Regional Outlook (Revenue, USD Million, 2016 – 2027)
List of Key Players of Implantable Neurostimulators Market
Browse Related Reports @
Ureteral Stents Market: https://www.grandviewresearch.com/industry-analysis/ureteral-stents-market
Direct Energy Medical Devices Market: https://www.grandviewresearch.com/industry-analysis/direct-energy-medical-devices-market
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
Media ContactCompany Name: Grand View Research, Inc.Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.Email: Send EmailPhone: 1-415-349-0058, Toll Free: 1-888-202-9519Address:201, Spear Street, 1100 City: San FranciscoState: CaliforniaCountry: United StatesWebsite: https://www.grandviewresearch.com/industry-analysis/implantable-neurostimulators-market